摘要
目的比较观察阿托伐他汀钙治疗高脂血症合并高尿酸血症的临床疗效。方法 60例高脂血症合并高尿酸血症,随机分为两组:阿托伐他汀钙组30例,口服阿托伐他汀钙20 mg;辛伐他汀组30例,口服辛伐他汀20 mg;均每晚睡前顿服1次,疗程8周。对比两组治疗前后总胆固醇(TC)、三酰甘油(TG)、低密度脂蛋白胆固醇(LDL-C)及高密度脂蛋白胆固醇(HDL-C)和血尿酸(BUA)的变化。结果两组治疗后TC、LDL-C、TG均有降低和HDL-C升高(P<0.05);但治疗后阿托伐他汀钙组血尿酸水平明显下降(P<0.05),而辛伐他汀组下降不明显(P>0.05);两组比较差异有统计学意义(P<0.05)。结论阿托伐他汀钙有较好的降脂外,还有降低血尿酸作用。所以对高脂血症合并高尿酸血症患者应首选阿托伐他汀钙。
Objective To compare the clinical effects of atorvastatin calcium in the treatment of hyperlipidemia with hyperuricemia.Methods 60 patients with hyperlipidemia and hyperuricemia were randomly divided into two groups: 30 cases of atorvastatin calcium group,who took orally atorvastatin calcium 20 mg;30 cases of simvastatin group,who took orally simvastatin 20 mg;and all took pills at a draught for one time before going to bed for 8 weeks,to compare the changes of total cholesterol(TC),triglyceride(TG),low density lipopro-tein cholesterol(LDL-C),high density lipoprotein cholesterol(HDL-C) and blood uric acid(BUA) before and after treatment.Results After treatment,TC,LDL-C,TG reduced and HDL-C increased in both-groups(P 0.05),but the atorvastatin calcium group's blood uric acid levels also decreased after treatment(P 0.05),with no significant decline in the simvastatin group(P 0.05).The comparison had significant difference between the two groups(P 0.05).Conclusion Atorvastatin calcium can not only lower the lipid well,but also lower the blood uric acid,so atorvastatin calcium should be preferred for hyperlipidemia patients complicated with hyperuricemia.
出处
《临床医学工程》
2011年第4期548-549,共2页
Clinical Medicine & Engineering